InvestorTransforming businesses for long-term success.
Aditum Bio
Aditum Bio is a biotech venture capital firm based in Oakland, California, focused on translating scientific discoveries into innovative medicines. The firm specializes in advancing drug candidates through the translational phase of development.
Online destinations
Find Aditum Bio online
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Official links
Pages the organization runs itself.
Overview
Aditum Bio is a biotech venture capital firm founded in 2019 by Joe Jimenez, former CEO of Novartis, and Dr. Mark Fishman, former President of the Novartis Institutes for BioMedical Research. Based in Oakland, California, the firm focuses on translating scientific discoveries into innovative medicines, aiming to improve patient outcomes by efficiently identifying and developing potentially first- and best-in-class therapies. Aditum Bio employs a unique investment model that allows for rapid company formation and execution, enabling the advancement of novel drug candidates into clinical trials.
Focus
Aditum Bio invests in the translational stage of drug development, targeting critical areas such as obesity, depression, substance abuse, renal disease, and infectious diseases. The firm is committed to advancing innovative therapies through a structured investment and operational approach, enabling the swift progression of drug candidates from concept to clinical trials.
Support
Aditum Bio adds value to its portfolio companies by leveraging its extensive industry experience and networks, facilitating access to funding, strategic partnerships, and operational support. The firm's unique investment model allows for rapid company formation and execution, ensuring that promising drug candidates are advanced efficiently through the development pipeline.
Questions
What are Aditum Bio's investment criteria?
Aditum Bio focuses on the translational stage of drug development, targeting areas such as obesity, depression, substance abuse, renal disease, and infectious diseases. The firm seeks to invest in preclinical assets that can be spun into standalone biotech companies.
How can I pitch to Aditum Bio?
Founders can submit inquiries through the general contact page on Aditum Bio's website. A well-prepared pitch deck should include details about the scientific basis of the project, market potential, and the team’s expertise.
What makes Aditum Bio different from other VCs?
Aditum Bio employs a unique company-creation model that allows for rapid formation and execution of biotech companies. This model enables the firm to advance drug candidates efficiently through the development pipeline.
What is the geographic focus of Aditum Bio?
The firm primarily operates in the United States, although it also partners with international entities, particularly in Asia, to access innovative assets.
What is the typical check size for investments?
Aditum Bio invests across various stages, including pre-seed, seed, Series A, Series B, and growth equity, with check sizes varying based on the stage and potential of the investment.
What kind of support does Aditum Bio provide to portfolio companies?
Aditum Bio adds value by leveraging its extensive industry experience and networks, facilitating access to funding, strategic partnerships, and operational support for its portfolio companies.
Check your startup’s fit
Check your startup’s fit with Aditum BioSimilar investors
Organizations that do similar work to Aditum Bio.
Investor
InvestorFounders Fund is a venture capital firm based in the United States, founded in 2005. It invests in technology companies across various sectors and stages.
InvestorGlobal private investment firm with diverse strategies.
InvestorInvesting in private markets for over 30 years.
Superscout Pro
Find faster. Show up verified. Keep your deals private.
$99a year, or $12 a month
Get Pro- Search that narrowsInvestors, programs, accelerators, incubators and studios, by stage, sector and place.
- A verified profileThe people you reach know you are who you say you are.
- A private deal vaultThe startups you are watching, with your notes and your reasons. Nobody else's eyes.
Is this page right?Reviewed · How the research works